Close Menu

NEW YORK — Clinical genomics informatics firm PierianDx said on Monday that it has closed a $27 million Series B financing round.

The round was led by ATW Partners and SJF Ventures, and included existing investors Health Catalyst Capital, Inova Health Systems, RTI International, and ARUP Laboratories.

St. Louis, Missouri-based PierianDx offers products and services for analyzing, interpreting, and reporting clinical next-generation sequencing data with a focus on cancer. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.